| An aminoglycoside antibiotic isolated from the bacterium streptomyces alboniger. Acting as an analog of the 3' terminal end of aminoacyl-tRNA, puromycin incorporates itself into a growing polypeptide chain and causes its premature termination, thereby inhibiting protein synthesis. This agent has antimicrobial, antitrypanosomal, and antineoplastic properties -- it is used as an antibiotic in cell culture. (NCI04) Puromycin is from the group Miscellaneous Antineoplastic Antibiotic
Protein Synthesis Inhibitor
Other Names for Puromycin
Puromycin
Adenosine, 3'-((2-amino-3-(4-methoxyphenyl)-1-oxopropyl)amino)-3'-deoxy-N,N-dimethyl-, (S)-
Adenosine, 3'-(alpha-amino-p-methoxyhydrocinnamamido)-3'-deoxy-N,N-dimethyl-, L-
CL 16536
L-3'-(alpha-Amino-p-methoxyhydrocinnamamido)-3'-deoxy-N,N-dimethyladenosine
P-638
Puromicina
Puromycine
Puromycinum
Stillomycin
Stylomycin
Source NCI Thesaurus License
|
Medical Dictionary 
